Metyrosine-associated endocrinological changes in pheochromocytoma and paraganglioma

OBJECTIVE: Metyrosine (alpha-methyl-para-tyrosine) effectively reduces catecholamine levels in patients with pheochromocytoma/paraganglioma. However, improvements in physiological and metabolic parameters and changes in endocrine function associated with metyrosine administration should be validated...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuo, Yuko, Ashida, Kenji, Nagayama, Ayako, Moritaka, Kanoko, Gobaru, Mizuki, Yasuda, Junichi, Ogasawara, Naoyuki, Kurose, Hirofumi, Chikui, Katsuaki, Iwata, Shimpei, Inoguchi, Yukihiro, Hasuzawa, Nao, Motomura, Seiichi, Igawa, Tsukasa, Nomura, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563611/
https://www.ncbi.nlm.nih.gov/pubmed/37822367
http://dx.doi.org/10.1530/EO-23-0006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563611/
https://www.ncbi.nlm.nih.gov/pubmed/37822367
http://dx.doi.org/10.1530/EO-23-0006

Ejemplares similares